*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| Z192 - Hormone resistant malignancy status - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 20.11 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 543: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 723: MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD Z192 - Hormone resistant malignancy status | 47 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD Z192 - Hormone resistant malignancy status in DRG | 5.96 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD Z192 - Hormone resistant malignancy status | 5.91 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD Z192 - Hormone resistant malignancy status | 30.95 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD Z192 - Hormone resistant malignancy status | 26.19 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD Z192 - Hormone resistant malignancy status | $586,273 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD Z192 - Hormone resistant malignancy status | $2,109 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD Z192 - Hormone resistant malignancy status | $12,474 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD Z192 - Hormone resistant malignancy status | $2,456,765 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD Z192 - Hormone resistant malignancy status | $52,272 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD Z192 - Hormone resistant malignancy status | NA | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD Z192 - Hormone resistant malignancy status | 27.66 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD Z192 - Hormone resistant malignancy status | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 542: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 105,234 | ||||
| Total Hospitalizations with ICD Z192 - Hormone resistant malignancy status | 25 | ||||
| DRG Share of Total Hospitalizations | 0.32 | ||||
| % of Total ICD Z192 - Hormone resistant malignancy status in DRG | 3.17 | ||||
| Avg LOS at DRG | 4.18 | ||||
| Avg LOS with ICD Z192 - Hormone resistant malignancy status | 4.0 | ||||
| Readmission Rate at DRG | 24.62 | ||||
| Readmission Rate with ICD Z192 - Hormone resistant malignancy status | NA | ||||
| Unplanned Readmission Rate at DRG | 17.79 | ||||
| Unplanned Readmission Rate with ICD Z192 - Hormone resistant malignancy status | NA | ||||
| Total Medicare payments at DRG | $723,145,698 | ||||
| Total Medicare payments with ICD Z192 - Hormone resistant malignancy status | $179,491 | ||||
| Total Medicare payment per Day at DRG | $1,644 | ||||
| Total Medicare payment per Day with ICD Z192 - Hormone resistant malignancy status | $1,795 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,872 | ||||
| Total Medicare payment per Hospitalization with ICD Z192 - Hormone resistant malignancy status | $7,180 | ||||
| Total Medicare Charges at DRG | $3,557,869,598 | ||||
| Total Medicare Charges with ICD Z192 - Hormone resistant malignancy status | $859,932 | ||||
| Avg Charges at DRG | $33,809 | ||||
| Avg Charges with ICD Z192 - Hormone resistant malignancy status | $34,397 | ||||
| Mortality Rate at DRG | 0.27 | ||||
| Mortality Rate with ICD Z192 - Hormone resistant malignancy status | NA | ||||
| SNF Discharge Rate at DRG | 20.33 | ||||
| SNF Discharge Rate with ICD Z192 - Hormone resistant malignancy status | NA | ||||
| Home Discharge Rate at DRG | 48.52 | ||||
| Home Discharge Rate with ICD Z192 - Hormone resistant malignancy status | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 713: TRANSURETHRAL PROSTATECTOMY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 669: TRANSURETHRAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 365,119 | ||||
| Total Hospitalizations with ICD Z192 - Hormone resistant malignancy status | 15 | ||||
| DRG Share of Total Hospitalizations | 1.11 | ||||
| % of Total ICD Z192 - Hormone resistant malignancy status in DRG | 1.9 | ||||
| Avg LOS at DRG | 5.91 | ||||
| Avg LOS with ICD Z192 - Hormone resistant malignancy status | 5.53 | ||||
| Readmission Rate at DRG | 27.73 | ||||
| Readmission Rate with ICD Z192 - Hormone resistant malignancy status | NA | ||||
| Unplanned Readmission Rate at DRG | 20.3 | ||||
| Unplanned Readmission Rate with ICD Z192 - Hormone resistant malignancy status | NA | ||||
| Total Medicare payments at DRG | $3,552,910,533 | ||||
| Total Medicare payments with ICD Z192 - Hormone resistant malignancy status | $135,500 | ||||
| Total Medicare payment per Day at DRG | $1,646 | ||||
| Total Medicare payment per Day with ICD Z192 - Hormone resistant malignancy status | $1,633 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,731 | ||||
| Total Medicare payment per Hospitalization with ICD Z192 - Hormone resistant malignancy status | $9,033 | ||||
| Total Medicare Charges at DRG | $16,860,985,198 | ||||
| Total Medicare Charges with ICD Z192 - Hormone resistant malignancy status | $762,542 | ||||
| Avg Charges at DRG | $46,179 | ||||
| Avg Charges with ICD Z192 - Hormone resistant malignancy status | $50,836 | ||||
| Mortality Rate at DRG | 5.06 | ||||
| Mortality Rate with ICD Z192 - Hormone resistant malignancy status | NA | ||||
| SNF Discharge Rate at DRG | 28.7 | ||||
| SNF Discharge Rate with ICD Z192 - Hormone resistant malignancy status | NA | ||||
| Home Discharge Rate at DRG | 32.16 | ||||
| Home Discharge Rate with ICD Z192 - Hormone resistant malignancy status | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|
| Total Hospitalizations at DRG | 499,133 | |
| Total Hospitalizations with ICD Z192 - Hormone resistant malignancy status | 11 | |
| DRG Share of Total Hospitalizations | 1.52 | |
| % of Total ICD Z192 - Hormone resistant malignancy status in DRG | 1.39 | |
| Avg LOS at DRG | 4.34 | |
| Avg LOS with ICD Z192 - Hormone resistant malignancy status | 5.09 | |
| Readmission Rate at DRG | 17.57 | |
| Readmission Rate with ICD Z192 - Hormone resistant malignancy status | NA | |
| Unplanned Readmission Rate at DRG | 12.56 | |
| Unplanned Readmission Rate with ICD Z192 - Hormone resistant malignancy status | NA | |
| Total Medicare payments at DRG | $3,254,711,780 | |
| Total Medicare payments with ICD Z192 - Hormone resistant malignancy status | $64,883 | |
| Total Medicare payment per Day at DRG | $1,504 | |
| Total Medicare payment per Day with ICD Z192 - Hormone resistant malignancy status | $1,159 | |
| Total Medicare payment per Hospitalization at DRG | $6,521 | |
| Total Medicare payment per Hospitalization with ICD Z192 - Hormone resistant malignancy status | $5,898 | |
| Total Medicare Charges at DRG | $16,863,396,143 | |
| Total Medicare Charges with ICD Z192 - Hormone resistant malignancy status | $341,317 | |
| Avg Charges at DRG | $33,785 | |
| Avg Charges with ICD Z192 - Hormone resistant malignancy status | $31,029 | |
| Mortality Rate at DRG | 1.33 | |
| Mortality Rate with ICD Z192 - Hormone resistant malignancy status | NA | |
| SNF Discharge Rate at DRG | 19.89 | |
| SNF Discharge Rate with ICD Z192 - Hormone resistant malignancy status | NA | |
| Home Discharge Rate at DRG | 49.27 | |
| Home Discharge Rate with ICD Z192 - Hormone resistant malignancy status | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 33 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 30 |
| KARMANOS CANCER CENTER | 4100 JOHN R ST | DETROIT | MI | 48201 | 15 |